Outcomes of COVID-19 patients treated with continuous positive airway pressure outside the intensive care unit
Rattachement africain : it. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
AIM: We aimed to characterise a large population of coronavirus disease 2019 (COVID-19) patients with moderate-to-severe hypoxaemic acute respiratory failure (ARF) receiving continuous positive airway pressure (CPAP) outside the intensive care unit (ICU), and to ascertain whether the duration of CPAP application increased the risk of mortality for patients requiring intubation. METHODS: In this retrospective, multicentre cohort study, we included adult COVID-19 patients, treated with CPAP outside ICU for hypoxaemic ARF from 1 March to 15 April, 2020. We collected demographic and clinical data, including CPAP therapeutic goal, hospital length of stay and 60-day in-hospital mortality. RESULTS: The study included 537 patients with a median (interquartile range (IQR) age of 69 (60-76) years. 391 (73%) were male. According to the pre-defined CPAP therapeutic goal, 397 (74%) patients were included in the full treatment subgroup, and 140 (26%) in the do not intubate (DNI) subgroup. Median (IQR) CPAP duration was 4 (1-8) days, while hospital length of stay was 16 (9-27) days. 60-day in-hospital mortality was 34% (95% CI 0.304-0.384%) overall, and 21% (95% CI 0.169-0.249%) and 73% (95% CI 0.648-0.787%) for full treatment and DNI subgroups, respectively. In the full treatment subgroup, in-hospital mortality was 42% (95% CI 0.345-0.488%) for 180 (45%) CPAP failures requiring intubation, and 2% (95% CI 0.008-0.035%) for the remaining 217 (55%) patients who succeeded. Delaying intubation was associated with increased mortality (hazard ratio 1.093, 95% CI 1.010-1.184). CONCLUSIONS: We described a large population of COVID-19 patients treated with CPAP outside ICU. Intubation delay represents a risk factor for mortality. Further investigation is needed for early identification of CPAP failures.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Outcomes of COVID-19 patients treated with continuous positive airway pressure outside the intensive care unit
- Date Crossref
- 29/10/2020
- Éditeur
- European Respiratory Society (ERS)
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Università degli Studi del Piemonte Orientale “Amedeo Avogadro” pays non établi dans la noticeUniversité ou école supérieure
-
Azienda Ospedaliero Universitaria Maggiore della Carita pays non établi dans la noticeOrganisme public
-
Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo pays non établi dans la noticeÉtablissement de santé
-
Ospedale degli Infermi pays non établi dans la noticeÉtablissement de santé
-
Presidio Ospedaliero pays non établi dans la noticeÉtablissement de santé
-
Azienda Ospedaliera Sant'Andrea pays non établi dans la noticeÉtablissement de santé
-
Santissima Trinità pays non établi dans la noticeÉtablissement de santé
-
University of Pavia pays non établi dans la noticeUniversité ou école supérieure
-
University of Padua pays non établi dans la noticeUniversité ou école supérieure
-
Azienda Ospedale - Università Padova pays non établi dans la noticeÉtablissement de santé
-
Azienda Ospedaliero Universitaria "Maggiore della Carità" pays non établi dans la noticeInstitution
-
These authors contributed equally pays non établi dans la noticeInstitution
Università degli Studi del Piemonte Orientale “Amedeo Avogadro”, Azienda Ospedaliero Universitaria Maggiore della Carita et Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo, avec 9 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.